How to apply for your certificate
Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more
Taking it as a reference at the conference in Clydebank last week means that it does not form part of official GPC Scotland policy.
But it is likely to fuel calls for debate over separate contracts at the UK LMCs conference in London next month.
John Rankin, from Forth Valley LMC, proposed the motion, saying the time was right to think about a separate contract.
‘I believe a contract is something you go into and honour. But we're working with the London government, which is not honourable.
‘We must have the opportunity to discuss our needs with the Scottish government,' he said.
Dr Alan McDevitt, from Greater Glasgow and Clyde LMC, said a separate contract had some appeal.
‘The main motivation is to defend the NHS because in England we're seeing the destruction of the NHS,' he said.
But having a Scottish contract would not be without its flaws, he said.
‘The trouble is that there's a strong need for a unified profession. The downside is that we're not going to achieve that.'
GPC Scotland chairman Dr Dean Marshall said that the Scottish government had been slow at showing it was different from Whitehall.
‘I have no confidence that they will be the saviours of general practice,' he said.
Conference coverage - Read all the latest articles from the event
Comment below and tell us what you think
Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more
Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more
The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more
Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more
Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more
Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more
Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more
Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more
Comments
Only registered users may comment. Log in now or register for a free account.